Skip to main content
. Author manuscript; available in PMC: 2007 Feb 1.
Published in final edited form as: Mech Dev. 2006 Jan 18;123(2):124–134. doi: 10.1016/j.mod.2005.11.004

Table 1.

Effects of varying SOX10 and EDNRB dosage on hypopigmentation

Severity of Hypopigmentation
Genotype No. I II III IV V
Tg(Dct-Sox10)/+CF1-10 20 100% 0 0 0 0
Tg(Dct-Sox10)/+2272 17 100% 0 0 0 0
Tg(Dct-Sox10)/+2245 8 100% 0 0 0 0
Tg(Dct-Sox10)/+2274 14 86% 14% 0 0 0
Sox10LacZ/+ 23 39% 61% 0 0 0
Sox10LacZ/+; Tg CF1-10 23 96% 4% 0 0 0
Ednrbs/s 5 0 0 100% 0 0
Ednrbs/s; Tg CF1-10 6 0 0 100% 0 0
Ednrbs/s–l 9 0 0 0 100% 0
Ednrbs/s–l; Tg CF1-10 6 0 0 0 100% 0
Ednrbs–l/s–l 1 0 0 0 0 100%
Ednrbs–l/s–l; Tg CF1-10 2 0 0 0 0 100%
Ednrbs/+ or Ednrbs–l/+ 16 44% 56% 0 0 0
Ednrbs/+; Tg CF1-10 or Ednrbs–l/+;Tg CF1-10 10 20% 80% 0 0 0
Ednrbs–l/+ 23 78% 22% 0 0 0
Ednrbs–l/+; Sox10Dom/+ 37 16% 84% 0 0 0
Sox10Dom/+ 14 7% 93% 0 0 0

No.:Number of animals used for the analysis

I: No hypopigmentation on dorsal or ventral surfaces

II: Ventral hypopigmentation only

III: Hypopigmentation over approximately 25% of the body surface area.

IV: Hypopigmentation over approximately 50 – 70% of the body surface area.

V: Hypopigmentation over approximately 95% of the body surface area.